# Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy

> **NCT06820320** · PHASE2 · COMPLETED · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 42 (actual)

## Conditions studied

- Chylous Ascites
- Abdominal Neoplasm
- Pelvic Neoplasms
- Retroperitoneal Lymph Node Metastasis
- Retroperitoneal Lymphadenectomy
- Extended Lymphadenectomy

## Interventions

- **DRUG:** oral iohexol
- **PROCEDURE:** Lymphangiography and Embolization

## Key facts

- **NCT ID:** NCT06820320
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820320, "Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06820320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*